Filter by: patients
What is Tylenol Extra Strength PM?

Tylenol Extra Strength PM is a combination of the pain reliever, acetaminophen and the sleep aid, diphenhydramine.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Insomnia 3 1 Efficacy_moderate
pain/sleeplessness 3 0
difficulty sleeping because of pain 3 0
Headaches 1 0
Other 1 1 Efficacy_none
Migraine headaches 1 0

See all 10 patients currently taking Tylenol Extra Strength PM

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
2

Reported Dosages

  500mg-25mg as needed 500 mg-25 mg daily 2 x 500 mg-25 mg daily 4 x 500 mg-25 mg daily
  4 Number of Patients: 4 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Tylenol Extra Strength PM (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 4   Other: 100%
Did not seem to work 1   Did not seem to work: 25%
Side effects too severe 1   Side effects too severe: 25%

See all 4 patients who’ve stopped taking Tylenol Extra Strength PM

Currently Taking Tylenol Extra Strength PM

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Tylenol Extra Strength PM

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Tylenol Extra Strength PM

Always
0 0%
Usually
1 50%
Sometimes
0 0%
Never
1 50%

Burden

Difficulty being on treatment

Burden of Tylenol Extra Strength PM

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

Cost of Tylenol Extra Strength PM

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.